Lady Lake, FL (PRWEB) January 06, 2015
Neil Riordan, PhD, co-founder of the Riordan-McKenna Institute, will present “The Role of Mesenchymal Stem Cells in the Reversal of Chronic Diseases” this Saturday, January 10th at the International Society for the Reversal of Chronic Diseases’ inaugural symposium: “Can Chronic Diseases be Reversed?” in Lady Lake, Florida.
The symposium will run from 8 a.m. to 4 p.m. at the Harbor Chase Village Crossing assisted living facility on NE 86th Dr. in The Villages across from The Villages Regional Hospital in Lady Lake, Florida 32159. The facility of golf cart accessible and lunch will be served to all attendees.
Tickets are $10 per person and RSVP is requires. Attendance is limited to 100 participants.
For more information or to purchase tickets, please contact Sheri Tor at 352-323-5506 or email: stor(at)CFHAlliance(dot)org. Credit card payments are accepted.
Distinguished guests include:
Moderator: Shalesh Kaushal, MD, PhD: Retina Specialty Institute
BS: Yale University; MD: John Hopkins; PhD: MIT, with Nobel Laureate Dr. Har Gobind Khorana
Caldwell B. Esselstyn Jr., MD, Cleveland Clinic
Retired endocrine surgeon and author
He and Dr. Colin Campbell recommended a diet adopted by President Bill Clinton.
T. Colin Campbell, PhD, Cornell University
Jacob Gould Schurman Professor Emeritus of Nutritional Biochemistry
Thomas M. Campbell, MD, Rochester University
Executive director of the T. Colin Campbell Center for Nutrition Studies and Author
Arthur L. Horwich, MD, Yale University
Biologist and the Eugene Higgins Professor of Genetics and Pediatrics at Yale School of Medicine
Randy L. Jirtle, MD, Duke University (Retired)
Biologist known for his pioneering work in epigenetics and genomic imprinting.
2007 nominee for Time Person of the Year
Amir Lerman, MD, Mayo Clinic
Professor of Medicine, Division of Cardiovascular Diseases and Internal Medicine
Neil Riordan, PhD, Founder and Chairman, Medistem; Co-founder Riordan-McKenna Institute of Regenerative Orthopedics (RMI)
Medistem is a leading stem cell laboratory research facility at the forefront of the effects of adult stem cells for chronic diseases. RMI specializes in surgical and non-surgical regenerative orthopedics.
Alessio Fasano, MD, Harvard University
Director, Mass. General Hospital for Children Center for Celiac Research; Division Chief, Dept. of Pediatric Gastroenterology and Nutrition
Toren Finkel, MD, PhD, National Heart Lung and Blood Institute (NIH)
Research focuses on molecular mechanisms of aging and impact on the treatment of age-related diseases.
About Neil Riordan PhD
Neil H. Riordan, PhD is the co-founder and chief science officer of the Riordan-McKenna Institute (RMI) in Southlake, Texas. RMI specializes in surgical and non-surgical regenerative orthopedics. RMI’s Stemnexa™ protocols incorporate the latest scientific advances in bone marrow harvesting, bone marrow aspirate concentration of stem cells and AlphaGEMS pliable tissue allograft.
Dr. Riordan is the founder and chairman of Medistem Panama, Inc., (MPI) a leading stem cell laboratory and research facility located in the Technology Park at the prestigious City of Knowledge in Panama City, Panama. Founded in 2007, MPI stands at the forefront of applied research on adult stem cells for several chronic diseases. MPI's stem cell laboratory is ISO 9001 certified and fully licensed by the Panamanian Ministry of Health. Dr. Riordan is the founder of Stem Cell Institute (SCI) in Panama City, Panama (est. 2007).
Under the umbrella of MPI subsidiary Translational Biosciences, MPI and SCI are currently conducting five IRB-approved clinical trials in Panama for multiple sclerosis, rheumatoid arthritis and osteoarthritis using human umbilical cord-derived mesenchymal stem cells, mesenchymal trophic factors and stromal vascular fraction. Additional trials for spinal cord injury, autism and cerebral palsy are slated to commence in 2014 upon IRB approval.
Dr. Riordan is an accomplished inventor; listed on more the 25 patent families, including 11 issued patents. He is credited with a number of novel discoveries in the field of cancer research since the mid-1990s when he collaborated with his father Dr. Hugh Riordan on the effects of high-dose intravenous vitamin C on cancer cells and the tumor microenvironment. This pioneering study on vitamin C’s preferential toxicity to cancer cells notably led to a 1997 patent grant for the treatment of cancer with vitamin C. In 2010, Dr. Riordan received another patent for a new cellular cancer vaccine.
Dr. Riordan is also the founder of Aidan Products, which provides health care professionals with quality nutraceuticals including Stem-Kine, the only nutritional supplement that is clinically proven to increase the amount of circulating stem cells in the body for an extended period of time. Stem-Kine is currently sold in 35 countries.
Dr. Riordan earned his Bachelor of Science at Wichita State University and graduated magna cum laude. He received his Master’s degree at the University of Nebraska Medical Center. Dr. Riordan completed his education by earning a Ph.D. in Health Sciences at Medical University of the Americas.
About Riordan-McKenna Institute
Riordan-McKenna Institute is the only orthopedic clinic that combines proprietary biologic cellular therapies with state-of-the-art orthopedic interventions to postpone or eliminate the need for surgery, or augment a necessary surgery for faster healing and better patient outcomes.
RMI’s Stemnexa™ protocols incorporate the latest scientific advances in bone marrow harvesting, bone marrow aspirate concentration of stem cells and AlphaGEMS pliable tissue allograft to decrease healing time, increase vascularization, decrease pain, reduce inflammation, decrease infection rates, and increase safety.
801 E. Southlake Blvd.
Southlake, TX 76092
Phone: (817) 776-8155
Toll Free: (877) 899-7836
Fax: (817) 776-8154
RMI Website: http://www.rmiclinic.com
About Stem Cell Institute Panama
Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.
In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for osteoarthritis, rheumatoid arthritis, and multiple sclerosis using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC), autologous stromal vascular fraction (SVF) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2014, Translation Biosciences expects to expand its clinical trial portfolio to include spinal cord injury, heart disease, autism and cerebral palsy.
For more information on stem cell therapy:
Stem Cell Institute Website: http://www.cellmedicine.com
Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama
About Medistem Panama Inc.
Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9001-certified laboratory in the prestigious City of Knowledge. The laboratory is fully licensed by the Panamanian Ministry of Health and features 3 class 10000 clean rooms, class 100 laminar flow hoods, and class 100 incubators.
Medistem Panama Inc.
Ciudad del Saber, Edif. 221 / Clayton
Panama, Rep. of Panama
Phone: +507 306-2601
Fax: +507 306-2601
About Translational Biosciences
A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.
Translational Biosciences Web Site: http://www.translationalbiosciences.com